If you lead cardiology or cardiac rehabilitation
How dosing works, how ReOxy® fits your programme and where to find the clinical data.
For clinics and rehabilitation centres
Individual dosing. A clear route into clinical practice.
For clinics: integrate individually dosed IHHT® into the care of your patients with coronary artery disease — supervised sessions, a Hypoxic Test to set the starting dose, and automatic test and treatment reports for your clinical workflow.
Intended use: improvement of physical exercise capacity in adult and senior patients with coronary artery disease (CAD).
For use in a clinical environment under professional supervision and according to a doctor's prescription.
If you manage the clinic or procurement
What implementation involves, which parameters drive the business case and which documents you will receive.
01
Why individual dosing
The measured response determines the individual dose.
A · INITIAL ASSESSMENT
Hypoxic Test
The Hypoxic Test characterises the individual oxygen-saturation and pulse response before treatment. The supervising physician confirms the treatment parameters.
B · RESPONSE-GUIDED DOSING
SRT® Technology
SRT® Technology uses the measured physiological response to guide hypoxic exposure and hyperoxic recovery throughout the treatment.
C · EVERY SESSION
Session and cycles
Session duration and the number of cycles are set for the individual treatment plan. Each cycle is guided by the patient’s measured response, and recovery continues until baseline SpO₂ is restored.
What is measured
ReOxy continuously measures SpO₂ and pulse rate using Masimo SET® pulse oximetry and displays perfusion index. The supplied-gas flow trace represents breathing pattern.
ReOxy® implements ICU/CCU-grade SpO₂ monitoring integrated into the measurement and control architecture.
See the full method
Phases, cycles and the illustrative response curve are explained on the method page.
How dosing works
02
Implementation and service
Plan the people, workflow and support.
What implementation involves for your team. Details are agreed with your biomedical engineering, clinical lead and data protection officer.
-
Site readiness and installation
Checklist to complete with your biomedical engineering: room, power, gas supply, data export and backup, hygiene of patient parts.
Provide 230 V~, 50 Hz power and at least 30 cm clearance from walls, curtains and large objects for air intake. Keep the air-cooled device away from heaters and do not stack it with other equipment. IFU operating range: +5 to +40°C; 15–95% relative humidity, non-condensing; altitude below 1000 m. Plan space for the chair, patient access and clinical supervision with the site team.
-
Operator training
Topics: intended use, contraindications and warnings · patient preparation, sensor and mask placement · Hypoxic Test and clinician confirmation of parameters · running a session, alarms and actions · reports and data protection · hygiene · incident reporting.
The device is used by trained specialists and instructed users. Configuration requires medical expertise. Training covers the IFU, patient preparation, the physician-confirmed Hypoxic Test, operation, alarms, reports, hygiene and incident reporting.
-
Clinical routine and documentation
Automatic test and treatment reports and session traceability for clinical workflows; storage for up to 1,000 patients and 100,000 reports.
-
Service and support
Who services the device in your country, response times, preventive maintenance, warranty and software updates.
The IFU specifies a two-year manufacturer warranty and a maintenance plan covering checks, filters and annual safety inspection. Country-specific service arrangements and commercial warranty terms are set out in the offer.
-
Data protection
Patient data stored on the device, export and backup, remote service access.
Test, treatment and course reports can be exported as PDF, with detailed procedure data in CSV via USB. The clinic’s data protection and IT teams define access, storage and backup for their configuration.
Engineering and manufacturing
AiMediq's dosing principle became ReOxy® through medical-device engineering with Bitmos — respiratory technology, patient monitoring and medical software. Gas-system performance and quality are checked in a dedicated test facility, separate from assembly.
Quality and manufacturing
03
Business overview
What we calculate together
The business overview for your management is built from your clinic's own figures. This page shows the parameters — not results.
- Your figuresEvery value comes from your clinic or from our price list. No assumed numbers.
- Transparent formulasYou see every formula and can change every parameter.
- Within the intended useScenarios cover patients with coronary artery disease in a clinical setting only.
ADevice and payment
- Purchase pricePrice list
- Leasing instalmentLessor
- Rental or subscription feePrice list
- Fee per sessionPrice list
- Service agreementPrice list
- Residual valueClinic
- Analysis horizonClinic
- Insurance and other fixed costsClinic
BOperations
- Session durationIFU
- Patient changeover timePilot
- Hypoxic Test per courseIFU
- Opening hours and working daysClinic
- Utilisation of slotsPilot
- Devices per staff memberIFU · Clinic
- Staff time per sessionPilot
- Staff and physician cost per hourClinic
- Consumables per sessionPrice list
CFinancing scenarios
- Self-pay price per courseClinic
- Per-session tariff, where one existsPayer
- Within the inpatient daily rate — programme value assessed separatelyClinic
- Research and grantsClinic
- Sessions per coursePhysician
DWhat you get
- Sessions and courses per year
- Break-even sessions per year
- Payback period
- Return over the horizon
- Total cost of ownership
- Purchase vs pay-per-session break point
- Sensitivity: utilisation, price, staffing
Showing parameters for: All models. Greyed-out parameters do not apply to the selected model.
This is an operational scenario based on the inputs shown, not a forecast of clinical outcomes or a guarantee of revenue. The prescribing physician determines the treatment plan.
04
Evidence
Clinical data for healthcare professionals
For healthcare professionals
Clinical data and publications
Request the relevant ReOxy publications from our medical team, with their study populations, results and limitations.
Published studies with ReOxy® are available to healthcare professionals and researchers on request from our medical team.
The clinical evidence begins with the European Long COVID rehabilitation study by Doehner et al.2024, followed by the broader ReOxy programme. Each result is presented with its population, design, intended-use context and limitations.
05
Pilot
Evaluate operational fit in your clinic
A time-limited evaluation checks whether ReOxy® fits your cardiac rehabilitation workflow, against criteria your clinic sets in writing before the start. It is not designed to demonstrate clinical effects.
A structured evaluation is agreed with the clinic before device placement, including its purpose, configuration, training, responsibilities and duration. A research study follows the applicable protocol and approval process.
- StartReadiness, installation, operator instruction
- Routine useWeekly check-in
- MidpointReview against criteria
- FinalReadout and go / no-go
Written evaluation agreement · fixed duration · no link to prescription volume.
Discuss a pilot| Criterion | Target | Measured by |
|---|---|---|
| Sessions per device per day | Set by your clinic | Device reports |
| Staff time per session | Set by your clinic | Time log |
| Patients completing the prescribed course | Set by your clinic | Course log |
| Technical availability | Set by your clinic | Downtime log |
| Documentation fits clinical workflow | Pass / fail | Head of rehabilitation |
06
Talk to us
Request a demo or talk to us
Tell us what you need: a demonstration, a clinical briefing, the business overview or the procurement pack.
- Clinic sales team
- [email protected]
Availability varies by country.